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Abstract
Chromium existing in the biosphere in prominent two forms Cr (III) and Cr
(VI) is a well-studied heavy metal. Cr (III) is considered as non-harmful and
necessary element in diet whereas Cr(VI) is extremely toxic exerting various nega-
tive health impacts on human and other organisms. Mining activity is must for
extracting economic minerals and a large number of people are related to these sites
as worker or habitants and a major source of chromium exposure. Present chapter
discusses genotoxic nature of chromium considering respiratory disease resulted
from chromium exposure. The genotoxicity is illustrated in terms of chromium
induced differential expressed genes (DEGs), transcription factors and microRNA
regulating the DEGs and their gene ontology.
Keywords: Mine tailing, Chromium Toxicity, Genotoxicity, Gene expressions
1. Introduction
For the growth of economy of a country and improving living status of popula-
tion, industrial functioning is mandatory which is in other hand associated activities
including supply of power, raw materials, processing and discharge of waste. For a
major section of industries, power supply is from coal or electricity generated from
coal, and the raw materials are various form of ores received from mining. Mine
tailing is the fine residual mine dump after completion of mining left with dug out
soil, scattered residuals and disturbed ecosystem. The major source of chromium in
the mine tailings is the residual ores present in traces not extracted with economic
point of view and mineral processing chemicals that are left unattended. Chromium
(Cr), a valuable element often finds its utility in metallurgical, chemical, and
refractory industries due to its pigment property, hardness and persistence. From
environment point of view, chromium exists in three oxidative states, elemental
chromium (0) that does not exist naturally, whereas trivalent chromium (Cr III) is
rather stable followed by hexavalent chromium (Cr VI) based on the different
number of electrons and therefore varied properties [1]. Hexavalent chromium is
extremely toxic even in low concentration and listed as carcinogenic, hematotoxic
and altering genetic material whereas, Cr (III) is regarded as micronutrient in
human diet. When Cr is left unattended in mine tailings, it can be transported by
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natural means to nearby waterbody, added with acid mine drainage, and surround-
ing ecosystem expanding the circumference of toxicity exposure [2]. This chapter
emphasises on toxicity of hexavalent chromium in genetic level that influence
expression of genes, the transcript factors controlling the differentially expressed
genes and finally to find out the major indicating and influenced genetic factors
with functional analysis of gene ontology for respiratory units of human.
1.1 Source and toxicity of chromium
Toxicity of chromium is directly influenced by the chromium species with
valence with number of electrons and thus their properties. The Cr(VI), is a pow-
erful oxidizing agent and plainly toxic to human and other organisms causing
adverse effect to blood cells, renal cells, allergic conditions and organs of most part
of body failure. Chromium can significantly find its route of exposures through
dermal chromium contact in waste sites, inhalation of chromium emissions and
ingestion of contaminated water or food grown in chromium contaminated soil.
Also, erosion products and emissions from road and cement dust, leather, paints
and or any Cr used materials contribute to inhalation of chromium. Dermal ulcers,
irritation and sensitization of respiratory/lungs are consecutive result of chromium
contact. In the plasma and cells, Cr(VI) readily get reduced to Cr(III), and thereaf-
ter excreted in the urine. Trivalent chromium is the form of chromium that is
essential to human health and counted as an essential trace mineral in the human
diet. Hexavalent chromium is recognised as genotoxic as it can damage genetic
information in living cells, causes DNA mutations, and possibly the formation of
cancerous tumours. Chromates (chromium salts) formed from hexavalent chro-
mium also finds utilization in manufacture leather products, paints, cement, mor-
tar, anti-corrosives, and other things. They are carcinogenic and allergenic.
1.2 Physiologic effects of chromium exposure in respiratory disease
Occupational exposures often include mixed exposure to both Cr(III) and Cr
(VI) [3]. Chromium compounds, when inhaled, causes respiratory tract irritants,
resulting in airway irritation, airway obstruction, and lung, nasal, or sinus cancer.
Radiographic analysis from several reports revealed enlargement of the hilar region
and lymph nodes [4, 5]. Consistent associations have been found between employ-
ment in the chromium industries and significant risk for respiratory cancer. Moller
et al. [6] reported systemic reactions characterised with anaphylactoid reaction in a
young welder having chromium (VI) vapor fume exposures. Following an experi-
ment with sodium chromate inhalation at a concentration of 29 μg/m3, formation of
static urticaria, angioedema and severe bronchospasm simultaneously with plasma
histamine rising in threefold was documented and suggested direct positive leuko-
cyte inhibitory factor of sodium chromate.
A number of nasal mucosa injury cases in Cr (VI) exposed workers at
concertation of nearly 20 μg/m3 (against US permissible standard 5 μg/m3) for
5 months to 10 years characterised with inflamed mucosa and ulcerated/perforated
septum was recorded in a study with 43 chrome-plating plants and tanneries in
Sweden [7, 8]. Huge number of complaints for nasal irritations was documented in
a detail epidemiological study with Tokyo (Japan) housewives residing near chro-
mium slag contaminated construction site [7]. U.S has recommended chromate and
chromic acid at workplace to be 5 μg/m3 as permissible standard. Gibb et al. [9]
observed that with less than 30 days median time for nasal ulceration diagnosis
from first exposure, median Cr (VI) concentration matched the Sweden report.
Occupational exposure to Cr(III) has also been associated with respiratory effects.
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Persons developed coughing, wheezing, and decreased forced volume after an
inhalation exposure to a sample of Cr(III) sulfate [10]. Combine effect of Cr(III)
and Cr(VI) as total chromium (0.02–0.19 mg total chromium/m3) investigated
among 60 ferrochromium workers squeezed out subjective symptoms of coughing,
wheezing, and dyspnea whereas control remained neutral [11]. These symptoms
might get puzzled with smoking issue to clarify the accurate problem of the diseases
[11]. While considering respiratory issue, animals are also often exposed to chro-
mium similar to the human. Henderson et al. [12] in histological examination with
exposure of 0.9–25 mg Cr(III) trichloride for 30 min observed alterations in lung
tissues associated with mild inflammation.
2. Chromium-gene interactions in respiratory disease
Comparative toxico-genomics database (CTD, http://ctdbase.org) is a
recognised well informed/updated, openly accessible database. It purposes to pro-
vide detail knowledge and information about the impacts of exposure of environ-
mental elements (pollutants) on human health.
The core block of the database basically manually curated contains updated
information regarding interaction and relationships among chemicals, genes, pro-
teins and their resulted specific disease in terms of functional and pathways to
incorporate new hypotheses expressing underlying mechanisms of disease and
environmental contamination [13].
3. Results and discussion
In this work, all Chromium- gene /protein interactions for respiratory disease
are downloaded from CTD, in which Chromium- gene /protein interactions associ-
ated to the following 04 respiratory disease are selected for further analysis
according to MESH ID used in CTD— Lung Neoplasma, Pulmonary Fibrosis and
Lung disease. Chromium- gene/protein interactions associated to this respiratory
disease are collected for further analysis. According to the reference score on rela-
tionships between chemicals-genes, genes-diseases and chemicals-diseases [14],
lung neoplasms is recognised as most likely having the maximum connectivity with
chromium. (Table 1). From the identified 168 chromium gene with in respiratory
disease, 131 genes are unique.
3.1 Gene function enrichment analysis
KEGG (http://www.genome.jp/) is a knowledge base for systematic analysis of
gene functions, linking genomic information with higher-order functional infor-
mation [15]. For the analysis of Gene Ontology (GO) and Kyoto Encyclopaedia of
Genes and Genomes (KEGG) pathway analysis, the Database for Annotation, Visu-
alization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov/) is a
great option. DAVID provides various functional annotation tools for researchers to
understand biological meaning behind large list of genes. [16] Gene ontology (GO)
analysis and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway enrich-
ment analysis can be performed for analysing differentially expressed genes (DEGs)
at the functional level based on DAVID Bioinformatics Resources 6.8. P < 0.05 as
the cut-off criterion. Researchers can upload all DEGs to the online software DAVID
to identify overrepresented GO categories and KEGG pathways. The curated genes
in CTD for each respiratory disease can be uploaded to DAVID 6.8 Beta (https://da
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vid-d.ncif-crf.gov/tools.jsp) with Homo sapiens as the background population [17]
for GO analysis.
GO analysis results for Cr toxicity in respiratory organs shows that that chro-
mium interacted genes in respiratory disease are involved in the biological processes
(BP) such as positive regulation of gene expression, positive regulation of cell
proliferation, response to drug positive regulation of protein phosphorylation.
(Table 2) For molecular function (MF), genes are enriched in identical protein
binding, enzyme binding, transcription factor binding and protein phosphatase
binding (Table 2). In addition, GO cell component (CC) analysis also displayed that
the gene are significantly enriched in the extracellular space, protein complex,
extracellular region and extracellular exosome (Table 2).
Table 3 contains the most significantly enriched pathways of the chromium
interacting genes by KEGG analysis. The interacting genes are enriched in Pathways
in cancer, Proteoglycans in cancer, HIF-1 signalling pathway and TNF signalling
pathways.
3.2 Gene-TFs-miRNAs regulation
The transcription factors (TFs) as well as microRNAs (miRNAs), are
recognised for their huge share in transacting and gene regulations with various
common logics and regulatory factors for gene regulation in multicellular genomes
[18, 19]. The library of ENCODE and ChEA Consensus TFs from ChIP-X in EnrichR
(http://amp.pharm.mssm.edu/Enrichr/ [20, 21]) can be used for the possible TFs
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ACE2, ACTA2, CAT, CCL11, CCL2, CCL5, CXCL8, EDN1,
FAM13A, FN1, FYN, HMGB1, HMOX1, IL1B, IL4, IL6, LAMB1,
MMP2, MMP9, MTOR, NFE2L2, PARP1, PDGFB, PTX3,
SERPINA1, SOD1,STAT3,TIMP1,TNF
29 25.25





TGFB1, TNF 02 5.86





Selected Respiratory diseases and related chromium-interacted gene.
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26 1.17E-21 2.49E-18 CRP, PDGFB, HIF1A, TNF, GJA1, FGF9,
ERBB3, MYC, ERBB2, HRAS, TGFB1, CAV1,
STAT3, FN1, MAPK14, MTOR, VEGFA,






14 1.39E-18 1.49E-15 EDN1, INSR, PTGS2, SOD2, ESR1, TNF, EGFR,
MTOR, IL6, IFNG, IL1B, AKT1, PTX3, TLR4
Positive regulation
of cell proliferation
26 1.23E-15 8.80E-13 CDKN1B, HILPDA, PDGFB, EGFR, IGF1R,
EFNB2, FGF9, MYC, MAPK1, SOX9, TIMP1,
HRAS, PDGFRA, EDN1, TGFB1, INSR, STAT3,
FN1, IL2, TGFBR2, VEGFA, AR, IL6, IFNG,
KIT, BCL2L1
Aging 18 1.68E-15 8.89E-13 JUN, TGFB1, OGG1, STAT3, FOS, TYMS,
EEF2, TGFBR2, SOD1, GCLC, IL6, CAT,
CYP1A1, SERPING1, CCL2, AKT1, TIMP1,
NFE2L2
Response to drug 22 2.08E-15 8.89E-13 CDKN1A, JUN, TGFB1, CDKN1B, OGG1,
STAT3, APOA1, FOS, TYMS, PTGS2, SOD2,
TGFBR2, SOD1, IL4, IL6, IFNG, CCND1, MYC,




13 7.81E-15 2.78E-12 JUN, EDN1, PDGFB, PTGS2, TNF, EGFR,





16 1.07E-14 3.27E-12 TGFB1, ANXA2, INSR, TNF, MMP9, EGFR,
MTOR, VEGFA, CCND1, CHEK2, IL1B,
ERBB2, AKT1, SOX9, HRAS, MAPK3
Term Count P value FDR Genes
Cellular Component
Extracellular space 49 1.61E-24 3.37E-22 SERPINA1, CXCL8, TFRC, HILPDA, LECT2,
HMGB1, TNF, FGF9, TIMP1, SFTPB, EDN1,
ANXA2, GPX3, MMP2, WNT5A, APOA1,
MMP9, MMP10, ACTA2, ACE2, AZGP1, IFNG,
IL1B, CAT, KIT, SERPING1, CRP, CCL11,
GSTP1, PDGFB, EGFR, ERBB3, PRDX1, CCL5,
CCL2, HMOX1, TGFB1, ACE, FN1, APOC3,
LAMB1, PRDX6, IL2, SOD1, VEGFA, IL4, IL6,
CPE, PTX3
Protein complex 21 1.48E-12 1.55E-10 PDGFRA, CDKN1A, FEN1, CDKN1B, PARP1,
CDKN2A, OGG1, CAV1, BRCA2, PTGS2,
SOD1, ACTA2, AR, MYC, COL6A1, AKT1,
MAPK1, CTNNB1, SOX9, TP53, MAPK3
Extracellular region 37 9.09E-12 6.36E-10 CRP, SERPINA1, CCL11, CXCL8, TFRC,
PDGFB, HMGB1, TNF, FGF9, CCL5, CCL2,
TIMP1, SFTPB, EDN1, TGFB1, ACE, GPX3,
MMP2, WNT5A, FN1, APOA1, APOC3,
LAMB1, MMP9, MMP10, IL2, SOD1, VEGFA,
IL4, ACE2, IL6, AZGP1, IFNG, IL1B, COL6A1,
SERPING1, PTX3
Cytosol 49 4.84E-09 2.54E-07 CDKN1A, CDKN1B, FAM13A, SMC2, SOX2,
GJA1, CASP8, CCND1, MYC, AKT1, HRAS,
GPX1, ANXA2, APOA1, FOS, TGFBR2,
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Term Count P value FDR Genes
ACTA2, AR, IL1B, DPYD, CAT, TP53, GSTP1,
TYMS, USP18, HIF1A, PRDX1, HMOX1,
MAPK1, FYN, HARS, MAP2K7, MAPK3, JUN,
GSTM1, NOS2, CDKN2A, STAT3, EEF2,
MAPK14, PRDX6, MTOR, SOD1, GCLC,
PDCD4, CTNNB1, FAS, NFE2L2, BCL2L1
Mitochondrion 26 7.77E-07 2.62E-05 FEN1, GSTP1, OGG1, COX17, TYMS, GJA1,
CASP8, MYC, PRDX1, CYP1B1, AKT1,
MAPK1, FYN, HARS, MAPK3, GPX1, PARP1,
CDKN2A, MMP2, MAPK14, SOD2, SOD1,
CAT, CYP1A1, TP53, BCL2L1
Membrane raft 11 7.89E-07 2.62E-05 ACE2, GJA1, CASP8, ANXA2, CAV1, FAS,
FYN, EEF2, TNF, EGFR, TGFBR2
Extracellular
exosome
40 8.72E-07 2.62E-05 CRP, SERPINA1, PCNA, TFRC, GSTP1, SMC2,
GJA1, FGF9, PRDX1, MAPK1, TIMP1, MAPK3,
ACE, GPX1, ANXA2, GPX3, INSR, WNT5A,
FN1, APOA1, APOC3, LAMB1, EEF2,
MAPK14, SOD2, MMP9, PRDX6, SOD1,
ACTA2, ACE2, BST1, AZGP1, CEACAM1,





31 2.03E-15 8.34E-13 SERPINA1, PCNA, TFRC, LECT2, PDGFB,
TNF, EGFR, IGF1R, CASP8, ERBB3, CHEK2,
PRDX1, ERBB2, AKT1, MAPK1, FYN, JUN,
PARP1, CAV1, STAT3, FN1, APOA1, SOD2,
MMP9, ESR1, SOD1, VEGFA, FAS, PTX3,
TP53, BCL2L1
Enzyme binding 22 9.84E-15 2.02E-12 JUN, TGFB1, GSTM1, PCNA, PARP1, CAV1,
APOA1, PTGS2, MAPK14, HIF1A, ESR1,
EGFR, AR, CCND1, CAT, CYP1A1, AKT1,
HMOX1, CTNNB1, FYN, MAP2K7, TP53
Transcription factor
binding
15 9.22E-09 1.13E-06 JUN, PARP1, CDKN2A, GPX3, STAT3,
HMGB1, FOS, HIF1A, ESR1, AR, CCND1,
MYC, MAPK1, CTNNB1, TP53
Protein phosphatase
binding
9 1.10E-08 1.13E-06 CEACAM1, CDKN1B, ERBB2, STAT3,
CTNNB1, MAPK14, MAP2K7, TP53, EGFR
Protein binding 90 3.45E-08 2.41E-06 CDKN1A, FEN1, CDKN1B, SERPINA1,
CXCL8, TFRC, OGG1, HILPDA, HMGB1,
BRCA2, TNF, IGF1R, SMC2, SOX2, GJA1,
CASP8, CCND1, MYC, CHEK2, AKT1, SOX9,
TIMP1, HRAS, PDGFRA, EDN1, PARP1,
ANXA2, GPX3, MMP2, WNT5A, APOA1, FOS,
MMP9, TGFBR2, ACE2, AR, AZGP1,
CEACAM1, DPYD, KIT, SERPING1, TLR4,
TP53, AVPI1, CRP, CCL11, PCNA, GSTP1,
COX17, PDGFB, PTGS2, USP18, HIF1A, EGFR,
EFNB2, ERBB3, TERT, PRDX1, CCL5, ERBB2,
HMOX1, MAPK1, FYN, MAP2K7, MAPK3,
EGR1, JUN, TGFB1, NOS2, CDKN2A, INSR,
CAV1, STAT3, FN1, EEF2, MAPK14, ESR1,
PRDX6, MTOR, SOD1, VEGFA, IL4, IL6,
CYP1A1, PDCD4, CTNNB1, FAS, PTX3,
NFE2L2, BCL2L1
Cytokine activity 12 3.53E-08 2.41E-06 IL4, IL6, EDN1, TGFB1, IFNG, IL1B, WNT5A,
TIMP1, HMGB1, TNF, IL2, VEGFA
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and related networks. The TargetScan library in EnrichR can be used for the possi-
ble miRNA interaction. TFs are identified to be significantly associated with the
genes involved in the respiratory disease. TRIM28, NFE2L2, EGR1 GATA2, PPARG,




21 1.14E-07 6.65E-06 PDGFRA, JUN, TGFB1, GSTM1, NOS2, TFRC,
PDGFB, TYMS, PTGS2, SOD1, VEGFA,
CEACAM1, TERT, ERBB3, CHEK2, CCL5, KIT,
DPYD, CAT, HMOX1, BCL2L1
Table 2.
Gene ontology analysis of Cr interacted genes.
Term Count P value FDR Genes
Pathways in
cancer
41 5.78E-24 5.60E-22 CDKN1A, CDKN1B, CXCL8, GSTP1, PDGFB,
BRCA2, PTGS2, HIF1A, EGFR, IGF1R, CASP8,
FGF9, CCND1, MYC, ERBB2, AKT1, MAPK1,
HRAS, MAPK3, PDGFRA, JUN, TGFB1, NOS2,
CDKN2A, MMP2, WNT5A, STAT3, FN1, LAMB1,
FOS, MMP9, MTOR, TGFBR2, VEGFA, AR, IL6,
KIT, CTNNB1, FAS, TP53, BCL2L1
Proteoglycans in
cancer
30 1.79E-21 8.69E-20 CDKN1A, HIF1A, TNF, EGFR, IGF1R, ERBB3,
CCND1, MYC, ERBB2, AKT1, MAPK1, HRAS,
MAPK3, TGFB1, CAV1, MMP2, WNT5A, STAT3,
FN1, MIR21, MAPK14, MMP9, ESR1, MTOR,
VEGFA, PDCD4, CTNNB1, FAS, TP53, TLR4
HIF-1 signaling
pathway
21 3.91E-18 1.26E-16 CDKN1A, EDN1, CDKN1B, NOS2, TFRC, INSR,
STAT3, HIF1A, EGFR, MTOR, IGF1R, VEGFA,





21 2.09E-17 5.07E-16 JUN, TGFB1, ACE, CXCL8, NOS2, FOS, MAPK14,
TNF, IL2, TGFBR2, IL6, CASP8, IFNG, IL1B,
CCL5, FAS, CCL2, AKT1, MAPK1, TLR4, MAPK3
Bladder cancer 14 1.10E-14 2.13E-13 CDKN1A, CXCL8, CDKN2A, MMP2, MMP9,
EGFR, VEGFA, CCND1, MYC, ERBB2, MAPK1,
HRAS, TP53, MAPK3
Hepatitis B 21 1.87E-14 3.02E-13 CDKN1A, JUN, TGFB1, CDKN1B, PCNA, CXCL8,
STAT3, FOS, TNF, MMP9, IL6, CASP8, CCND1,
MYC, FAS, AKT1, MAPK1, HRAS, TP53, TLR4,
MAPK3
Prostate cancer 16 1.94E-12 2.69E-11 PDGFRA, CDKN1A, CDKN1B, PDGFB, EGFR,
MTOR, IGF1R, AR, CCND1, ERBB2, AKT1,
MAPK1, CTNNB1, HRAS, TP53, MAPK3
TNF signaling
pathway
17 2.75E-12 3.34E-11 JUN, EDN1, FOS, PTGS2, MAPK14, TNF, MMP9,




14 7.57E-12 8.16E-11 TGFB1, CDKN2A, STAT3, BRCA2, EGFR,
TGFBR2, VEGFA, CCND1, ERBB2, AKT1,
MAPK1, TP53, BCL2L1, MAPK3
HTLV-I
infection
23 1.29E-11 1.25E-10 PDGFRA, EGR1, CDKN1A, JUN, TGFB1, PCNA,
CDKN2A, WNT5A, PDGFB, FOS, TNF, IL2,
TGFBR2, IL6, TERT, CCND1, CHEK2, MYC,
AKT1, CTNNB1, HRAS, TP53, BCL2L1
Table 3.
Pathway analysis for the chromium interacting genes related to Respiratory Disease.
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ZMIZ1 and ESR1 are significant for respiratory disease influencing DEGs. The
regulated genes for each of these TFs for chromium toxicity are shown in Table 4
followed by the miRNAs identified for chromium interacting genes involved in the
Respiratory diseases in Figure 1.
3.3 Comparable chemicals
Information about biological effects of a chemical at genetic level can be exten-
sively extracted from CTD to create new hypotheses with a lot of interaction
pathways and networks among genes-contaminants and diseases [22].
This highly contributes in identifying similar contaminants responsible for spe-
cific diseases. Comparable chemicals extracted from CTD for the possible sharing
with many of the networks common to chromium in respiratory disease are given in
Table 5. Mercury, SB 203580, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-
one, 2,3-dimethoxy-1,4-naphthoquinone, were found interacting with 102,
81,77and 61 chromium-iInteracting genes in Respiratory disease.





TRIM28 9/210 1.02E-05 9.92E-04 82.94725092 EFNB2;EGR1;JUN;PARP1;ERBB3;
WNT5A;SOX9;HIF1A;SOD1




EGR1 10/315 4.37E-05 0.001413873 53.21069483 EGR1;JUN;SERPINA1;STAT3;AKT1;
MAPK1;ESR1;MMP9;EGFR;SOD1
GATA2 15/772 1.64E-04 0.003970477 28.45933865 JUN;CDKN1A;EDN1;GPX1;MMP2;
LAMB1;FOS;MAPK14;IGF1R;IL4;
CHEK2;PDCD4;IDS;IER2;BCL2L1
PPARG 12/535 2.10E-04 0.004075587 31.58677746 EFNB2;PDGFRA;JUN;CDKN1A;
CASP8;INSR;HILPDA;CYP1B1;FOS;
BCL2L1;SOD1;VEGFA




ESR1 6/154 5.36E-04 0.006683025 48.17527072 EDN1;SERPINA1;STAT3;CYP1B1;
FOS;ESR1
CTCF 24/1790 5.51E-04 0.006683025 17.25236108 PDGFRA; EGR1; JUN; EDN1; TGFB1;
PCNA; CAV1; APOA1; EEF2;




MYC 11/573 0.001387281 0.014951805 20.72253353 GJA1; GCLC; PCNA; TFRC; CCND1;
TERT;PARP1;EEF2;TP53;IER2;SOD1
RAD21 17/1265 0.003726145 0.036105828 12.44311845 PDGFRA; JUN; EDN1; PCNA;
APOA1; EEF2; MAPK14; SOD2;
VEGFA; EFNB2; IL6; CEACAM1;
CASP8; MYC; TP53; BCL2L1;NFE2L2
Table 4.
Transcription factors for the chromium interacting genes involved in the Respiratory diseases.
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Figure 1.
Gene-TFs-miRNA Interaction Network.




2,3-dimethoxy-1,4-naphthoquinone 6956-96-3 0.174285714 61
Niacin 0.150997151 53
Antimony 7440-36-0 0.143333333 43
Antimony Potassium Tartrate 28300-74-5 0.132183908 46
naringin 10236-47-2 0.131016043 49
SB 203580 0.13022508 81
Mercury 7439-97-6 0.129606099 102
Rutin 153-18-4 0.129518072 43
alpha-Tocopherol 59-02-9 0.126262626 50





Luteolin 491-70-3 0.122395833 47
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4. Conclusions
Chromium (VI) is a vital toxic environmental pollutant having various sources
including mine tailings. This chapter enlighten respiratory disease accelerated as
well as caused due to chromium exposure at genetic level following bioinformatics
method that leverages curated data from the public database CTD to generate novel
sets of information. This strategy does not require a priori knowledge of the toxi-
cant, biological system, or adverse outcome, and it can be used to identify potential
molecular and biological intermediary steps that help fill in knowledge gaps
connecting chemical exposures with outcomes for environmentally influenced dis-
eases. With the existed data libraries (mainly CTD, GO, pathway, TFs and miRNA
relate databases), bioinformatics web-based tools (David and EnrichR), BPs, CCs,
MFs, KEEG signal pathways and gene regulation in the chromium-gene-disease
networks were presented. In this study, 127 genes are identified as affected by
exposure CR(VI), which are majorly regulated by 10 TFs and 10 very high target
miRNAs. The Gene-TFs-miRNAs network recognises maximum interacted genes
(EFNB2, IGF1R, CYP1B1, INSR, and VEGFA) and TFs (ZMIZ1, NFE2L2, CTCF and
RAD21) and miRNAs (hsa-miR-4506, hsa-miR-379, hsa-miR-3529, hsa-miR-4535,
hsa-miR-3684, and hsa-miR-409-5p). The significant biological process (positive
regulation of gene expression and positive regulation of nitric oxide biosynthetic
process), Cellular Component (extracellular space and protein complex) and
Molecular Function (identical protein binding and enzyme binding) are influenced
by chromium exposures. From pathway analysis of Cr (VI) influence on respiratory
disease, maximum of DEGs are identified to be involved in various pathways in
cancer (41 nos.) followed by proteoglycans in cancer (30 nos.), and HTLV-I
infection (23 nos.) and so on. Comparable contaminants analysis has recognised
Mercury, SB 203580, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one and
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one to have maximum
common DEGs with Cr (VI) exposure.







Thioctic Acid 62-46-4 0.121890547 49





Docosahexaenoic Acids 25167-62-8 0.117073171 48
Table 5.
Chemicals having comparable sets of interacting genes to chromium.
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